Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Angiotensin II type 2 receptor (AT2R) is a G protein-coupled receptor and one of the two main receptors for angiotensin II, a key hormone in the renin–angiotensin system (RAS). While the AT1 receptor mediates most classical effects of angiotensin II (vasoconstriction, cell growth), the AT2R often counterbalances these actions, contributing to vasodilation, inhibiting cell growth, and promoting apoptosis. It is highly expressed in fetal tissues but decreases after birth, being upregulated in adults under pathological conditions. Recent research focuses on developing selective ligands to harness its protective properties against hypertension-induced organ damage and other conditions.
G protein-coupled receptor signaling; nitric oxide production; cGMP-mediated cellular responses; vasodilation; anti-proliferation; apoptosis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiotensin II type 2 receptor (AT2R).